PUBLISHER: Value Market Research | PRODUCT CODE: 1274199
PUBLISHER: Value Market Research | PRODUCT CODE: 1274199
Global Stuttering Therapeutics Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030
The global demand for Stuttering Therapeutics Market is presumed to reach the market size of nearly USD 140.98 BN by 2030 from USD 46.09 BN in 2022 with a CAGR of 15% under the study period 2023 - 2030.
Stuttering therapeutics refers to the various treatments and interventions that aim to help individuals who stutter improve their speech fluency and communication skills. Stuttering is a speech disorder affecting the flow of speech, repetitions of sounds or words, prolongations of sounds, and blocks or involuntary pauses. There are several approaches to stuttering therapeutics, including speech therapy, behavioural therapy, cognitive therapy, fluency shaping therapy, and stuttering modification therapy.
Market Dynamics:
The prevalence of stuttering is estimated to be around 1% of the global population, with the disorder being more common in males than females. As the global population grows, the number of individuals with stuttering is also expected to increase, driving demand for stuttering therapeutics. With growing awareness and acceptance of stuttering as a disorder, individuals with stuttering are becoming more vocal about their experiences and seeking treatment which has assisted in increasing the demand for stuttering therapeutics. There have been significant advancements in the development of stuttering therapeutics, including the use of electronic devices, medications, and speech therapy techniques. These advancements have led to more effective treatment options, driving demand for stuttering therapeutics.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of stuttering therapeutics. The growth and trends of stuttering therapeutics industry provide a holistic approach to this study.
Market Segmentation:
This section of the stuttering therapeutics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Treatment
- Speech Therapy
- Stuttering Devices
- Cognitive Behavioural Therapy
- Parent-Child Interaction
- Drug Therapy
By Type
- Developmental Stuttering
- Neurogenic Stuttering
By End User
- Hospitals
- Specialty Clinics
- Homecare
Regional Analysis:
This section covers the regional outlook, which accentuates current and future demand for the Stuttering Therapeutics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the stuttering therapeutics market include Competition Deep Dive, Auspex Pharmaceuticals Inc., GlaxoSmithKline plc., Johnson & Johnson Services, Merck & Co. Inc., Pfizer Inc., Siemens Healthcare GmbH, Novartis AG, AstraZeneca, AbbVie Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
TABLE OF CONTENTS
1 . PREFACE
- 1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
- 1.2. Research Scope
- 1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology
2 . EXECUTIVE SUMMARY
- 2.1. Highlights of Market
- 2.2. Global Market Snapshot
3 . STUTTERING THERAPEUTICS - INDUSTRY ANALYSIS
- 3.1. Introduction - Market Dynamics
- 3.2. Market Drivers
- 3.3. Market Restraints
- 3.4. Opportunities
- 3.5. Industry Trends
- 3.6. Porter's Five Force Analysis
- 3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Treatment
- 3.7.2 Market Attractiveness Analysis By Type
- 3.7.3 Market Attractiveness Analysis By End User
- 3.7.4 Market Attractiveness Analysis By Region
4 . VALUE CHAIN ANALYSIS
- 4.1. Value Chain Analysis
- 4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
- 4.3. List of Potential Buyers
- 4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend
5 . GLOBAL STUTTERING THERAPEUTICS MARKET ANALYSIS BY TREATMENT
- 5.1 Overview by Treatment
- 5.2 Historical and Forecast Data
- 5.3 Analysis by Treatment
- 5.4 Speech Therapy Historic and Forecast Sales by Regions
- 5.5 Stuttering Devices Historic and Forecast Sales by Regions
- 5.6 Cognitive Behavioural Therapy Historic and Forecast Sales by Regions
- 5.7 Parent-Child Interaction Historic and Forecast Sales by Regions
- 5.8 Drug Therapy Historic and Forecast Sales by Regions
6 . GLOBAL STUTTERING THERAPEUTICS MARKET ANALYSIS BY TYPE
- 6.1 Overview by Type
- 6.2 Historical and Forecast Data
- 6.3 Analysis by Type
- 6.4 Developmental Stuttering Historic and Forecast Sales by Regions
- 6.5 Neurogenic Stuttering Historic and Forecast Sales by Regions
7 . GLOBAL STUTTERING THERAPEUTICS MARKET ANALYSIS BY END USER
- 7.1 Overview by End User
- 7.2 Historical and Forecast Data
- 7.3 Analysis by End User
- 7.4 Hospitals Historic and Forecast Sales by Regions
- 7.5 Specialty Clinics Historic and Forecast Sales by Regions
- 7.6 Homecare Historic and Forecast Sales by Regions
8 . GLOBAL STUTTERING THERAPEUTICS MARKET ANALYSIS BY GEOGRAPHY
- 8.1. Regional Outlook
- 8.2. Introduction
- 8.3. North America Sales Analysis
- 8.3.1. Overview, Historic and Forecast Data Sales Analysis
- 8.3.2. North America By Segment Sales Analysis
- 8.3.3. North America By Country Sales Analysis
- 8.3.4. United State Sales Analysis
- 8.3.5. Canada Sales Analysis
- 8.3.6. Mexico Sales Analysis
- 8.4. Europe Sales Analysis
- 8.4.1. Overview, Historic and Forecast Data Sales Analysis
- 8.4.2. Europe by Segment Sales Analysis
- 8.4.3. Europe by Country Sales Analysis
- 8.4.4. United Kingdom Sales Analysis
- 8.4.5. France Sales Analysis
- 8.4.6. Germany Sales Analysis
- 8.4.7. Italy Sales Analysis
- 8.4.8. Russia Sales Analysis
- 8.4.9. Rest Of Europe Sales Analysis
- 8.5. Asia Pacific Sales Analysis
- 8.5.1. Overview, Historic and Forecast Data Sales Analysis
- 8.5.2. Asia Pacific by Segment Sales Analysis
- 8.5.3. Asia Pacific by Country Sales Analysis
- 8.5.4. China Sales Analysis
- 8.5.5. India Sales Analysis
- 8.5.6. Japan Sales Analysis
- 8.5.7. South Korea Sales Analysis
- 8.5.8. Australia Sales Analysis
- 8.5.9. Rest Of Asia Pacific Sales Analysis
- 8.6. Latin America Sales Analysis
- 8.6.1. Overview, Historic and Forecast Data Sales Analysis
- 8.6.2. Latin America by Segment Sales Analysis
- 8.6.3. Latin America by Country Sales Analysis
- 8.6.4. Brazil Sales Analysis
- 8.6.5. Argentina Sales Analysis
- 8.6.6. Peru Sales Analysis
- 8.6.7. Chile Sales Analysis
- 8.6.8. Rest of Latin America Sales Analysis
- 8.7. Middle East & Africa Sales Analysis
- 8.7.1. Overview, Historic and Forecast Data Sales Analysis
- 8.7.2. Middle East & Africa by Segment Sales Analysis
- 8.7.3. Middle East & Africa by Country Sales Analysis
- 8.7.4. Saudi Arabia Sales Analysis
- 8.7.5. UAE Sales Analysis
- 8.7.6. Israel Sales Analysis
- 8.7.7. South Africa Sales Analysis
- 8.7.8. Rest Of Middle East And Africa Sales Analysis
9 . COMPETITIVE LANDSCAPE OF THE STUTTERING THERAPEUTICS COMPANIES
- 9.1. Stuttering Therapeutics Market Competition
- 9.2. Partnership/Collaboration/Agreement
- 9.3. Merger And Acquisitions
- 9.4. New Product Launch
- 9.5. Other Developments
10 . COMPANY PROFILES OF STUTTERING THERAPEUTICS INDUSTRY
- 10.1. Company Share Analysis
- 10.2. Market Concentration Rate
- 10.3. Competition Deep Dive
- 10.3.1. Company Overview
- 10.3.2. Company Revenue
- 10.3.3. Products
- 10.3.4. Recent Developments
- 10.4. Auspex Pharmaceuticals Inc.
- 10.4.1. Company Overview
- 10.4.2. Company Revenue
- 10.4.3. Products
- 10.4.4. Recent Developments
- 10.5. GlaxoSmithKline plc.
- 10.5.1. Company Overview
- 10.5.2. Company Revenue
- 10.5.3. Products
- 10.5.4. Recent Developments
- 10.6. Johnson & Johnson Services
- 10.6.1. Company Overview
- 10.6.2. Company Revenue
- 10.6.3. Products
- 10.6.4. Recent Developments
- 10.7. Merck & Co. Inc.
- 10.7.1. Company Overview
- 10.7.2. Company Revenue
- 10.7.3. Products
- 10.7.4. Recent Developments
- 10.8. Pfizer Inc.
- 10.8.1. Company Overview
- 10.8.2. Company Revenue
- 10.8.3. Products
- 10.8.4. Recent Developments
- 10.9. Siemens Healthcare GmbH
- 10.9.1. Company Overview
- 10.9.2. Company Revenue
- 10.9.3. Products
- 10.9.4. Recent Developments
- 10.10. Novartis AG
- 10.10.1. Company Overview
- 10.10.2. Company Revenue
- 10.10.3. Products
- 10.10.4. Recent Developments
- 10.11. AstraZeneca
- 10.11.1. Company Overview
- 10.11.2. Company Revenue
- 10.11.3. Products
- 10.11.4. Recent Developments
- 10.12. AbbVie Inc.
- 10.12.1. Company Overview
- 10.12.2. Company Revenue
- 10.12.3. Products
- 10.12.4. Recent Developments
Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
LIST OF TABLES
- Market Snapshot
- Drivers : Impact Analysis
- Restraints : Impact Analysis
- List of Raw Material
- List of Raw Material Manufactures
- List of Potential Buyers
- Analysis by Treatment (USD MN)
- Speech Therapy Market Sales by Geography (USD MN)
- Stuttering Devices Market Sales by Geography (USD MN)
- Cognitive Behavioural Therapy Market Sales by Geography (USD MN)
- Parent-Child Interaction Market Sales by Geography (USD MN)
- Drug Therapy Market Sales by Geography (USD MN)
- Analysis Market by Type (USD MN)
- Developmental Stuttering Market Sales by Geography (USD MN)
- Neurogenic Stuttering Market Sales by Geography (USD MN)
- Analysis by End User (USD MN)
- Hospitals Market Sales by Geography (USD MN)
- Specialty Clinics Market Sales by Geography (USD MN)
- Homecare Market Sales by Geography (USD MN)
- Global Stuttering Therapeutics Market Sales by Geography (USD MN)
- North America Market Analysis (USD MN)
- United State Market Analysis (USD MN)
- Canada Market Analysis (USD MN)
- Mexico Market Analysis (USD MN)
- Europe Market Analysis (USD MN)
- Europe Market Estimate by Country (USD MN)
- United Kingdom Market Analysis (USD MN)
- France Market Analysis (USD MN)
- Germany Market Analysis (USD MN)
- Italy Market Analysis (USD MN)
- Russia Market Analysis (USD MN)
- Spain Market Analysis (USD MN)
- Rest of Europe Market Analysis (USD MN)
- Asia Pacific Market Analysis (USD MN)
- China Market Analysis (USD MN)
- Japan Market Analysis (USD MN)
- India Market Analysis (USD MN)
- South Korea Market Analysis (USD MN)
- Australia Market Analysis (USD MN)
- Rest of Asia Pacific Market Analysis (USD MN)
- Latin America Market Analysis (USD MN)
- Brazil Market Analysis (USD MN)
- Argentina Market Analysis (USD MN)
- Peru Market Analysis (USD MN)
- Chile Market Analysis (USD MN)
- Rest of Latin America Market Analysis (USD MN)
- Middle East & Africa Market Analysis (USD MN)
- Saudi Arabia Market Analysis (USD MN)
- UAE Market Analysis (USD MN)
- Israel Market Analysis (USD MN)
- South Africa Market Analysis (USD MN)
- Rest of Middle East and Africa Market Analysis (USD MN)
- Partnership/Collaboration/Agreement
- Mergers And Acquisition
LIST OF FIGURES
- Research Scope of Stuttering Therapeutics Report
- Market Research Process
- Market Research Methodology
- Global Stuttering Therapeutics Market Size, by Region (USD MN)
- Porters Five Forces Analysis
- Market Attractiveness Analysis by Treatment
- Market Attractiveness Analysis by Type
- Market Attractiveness Analysis by End User
- Market Attractiveness Analysis by Region
- Value Chain Analysis
- Global Market Analysis by Treatment (USD MN)
- Speech Therapy Market Sales by Geography (USD MN)
- Stuttering Devices Market Sales by Geography (USD MN)
- Cognitive Behavioural Therapy Market Sales by Geography (USD MN)
- Parent-Child Interaction Market Sales by Geography (USD MN)
- Drug Therapy Market Sales by Geography (USD MN)
- Global Market Analysis by Type (USD MN)
- Developmental Stuttering Market Sales by Geography (USD MN)
- Neurogenic Stuttering Market Sales by Geography (USD MN)
- Global Market Analysis by End User (USD MN)
- Hospitals Market Sales by Geography (USD MN)
- Specialty Clinics Market Sales by Geography (USD MN)
- Homecare Market Sales by Geography (USD MN)
- Global Market Sales (USD MN)
- North America Market Sales (USD MN)
- Europe Market Sales (USD MN)
- Asia Pacific Market Sales (USD MN)
- Latin America Market Sales (USD MN)
- Middle East & Africa Market Sales (USD MN)
- Recent Development in Industry
- Top Company Market Share Analysis
Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.
